2016 annual financial data
Dyne Therapeutics 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was 49.49%.
Operating income was -640,000,000 USD and net income was -1,240,000,000 USD.
Operating cash flow was 676,000,000 USD.
Get free Dyne Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,366,000,000 USD
- Operating income
- -640,000,000 USD
- Net income
- -1,240,000,000 USD
- Operating cash flow
- 676,000,000 USD